Prevalence of Abnormal Involuntary Movements ("spontaneous Dyskinesias") in the Normal Elderly

Overview

Journal Psychopharmacology (Berl)

Specialty Pharmacology

Date 1982 Jan 1

PMID 6812127

Citations 8

Authors

J M Kane

P Weinhold

B Kinon

J Wegner

M Leader

Affiliations

Soon will be listed here.

Abstract

Advancing age has been associated with increased prevalence of abnormal involuntary movements in neuroleptic-treated patients. In order to investigate the possibility that the aging process itself might produce involuntary movements clinically indistinguishable from tardive dyskinesia, a group of healthy elderly volunteers were systematically examined. A 4% prevalence rate of mild involuntary movements was found, suggesting that the aging process itself is not likely to produce dyskinesias without other contributing factors coming into play.

Citing Articles

Movement disorders of the mouth: a review of the common phenomenologies.

Ghadery C, Kalia L, Connolly B J Neurol. 2022; 269(11):5812-5830.

PMID: 35904592 DOI: 10.1007/s00415-022-11299-1.

Overcoming barriers to effective management of tardive dyskinesia.

Caroff S Neuropsychiatr Dis Treat. 2019; 15:785-794.

PMID: 31040678 PMC: 6459148. DOI: 10.2147/NDT.S196541.

Response to Letter to the Editor.

Friedman J, DAbreu A Tremor Other Hyperkinet Mov (N Y). 2019; 9:630.

PMID: 30783554 PMC: 6377913. DOI: 10.7916/0rjw-cv10.

Antipsychotic-induced movement disorders: evaluation and treatment.

Mathews M, Gratz S, Adetunji B, George V, Mathews M, Basil B Psychiatry (Edgmont). 2010; 2(3):36-41.

PMID: 21179628 PMC: 3004713.

Extrapyramidal symptoms with atypical antipsychotics : incidence, prevention and management.

Pierre J Drug Saf. 2005; 28(3):191-208.

PMID: 15733025 DOI: 10.2165/00002018-200528030-00002.

References

ECKMANN F . [On the problem of permanent damage following prolonged neuroleptic treatment]. Ther Ggw. 1968; 107(3):316 passim. View

Kane J, Smith J . Tardive dyskinesia: prevalence and risk factors, 1959 to 1979. Arch Gen Psychiatry. 1982; 39(4):473-81. DOI: 10.1001/archpsyc.1982.04290040069010. View

McGeer P, McGeer E, Suzuki J . Aging and extrapyramidal function. Arch Neurol. 1977; 34(1):33-5. DOI: 10.1001/archneur.1977.00500130053010. View

Robinson D, Davis J, Nies A, RAVARIS C, Sylwester D . Relation of sex and aging to monoamine oxidase activity of human brain, plasma, and platelets. Arch Gen Psychiatry. 1971; 24(6):536-9. DOI: 10.1001/archpsyc.1971.01750120052009. View

CRANE G, Smeets R . Tardive dyskinesia and drug therapy in geriatric patients. Arch Gen Psychiatry. 1974; 30(3):341-3. DOI: 10.1001/archpsyc.1974.01760090055009. View

Freund G . Cholinergic receptor loss in brains of aging mice. Life Sci. 1980; 26(5):371-5. DOI: 10.1016/0024-3205(80)90153-8. View

CRANE G . Persistent dyskinesia. Br J Psychiatry. 1973; 122(569):395-405. DOI: 10.1192/bjp.122.4.395. View

Simpson G, Lee J, Zoubok B, Gardos G . A rating scale for tardive dyskinesia. Psychopharmacology (Berl). 1979; 64(2):171-9. DOI: 10.1007/BF00496058. View

Mettler F, CRANDELL A . Neurologic disorders in psychiatric institutions. J Nerv Ment Dis. 1959; 128(2):148-59. View

10.

Hippius H, Lange J . [Late extrapyramidal hyperkineses after prolonged neuroleptic therapy]. Arzneimittelforschung. 1970; 20(7):888-90. View

11.

Smith J, Baldessarini R . Changes in prevalence, severity, and recovery in tardive dyskinesia with age. Arch Gen Psychiatry. 1980; 37(12):1368-73. DOI: 10.1001/archpsyc.1980.01780250054006. View

12.

Davis J . Overview: maintenance therapy in psychiatry: I. Schizophrenia. Am J Psychiatry. 1975; 132(12):1237-45. DOI: 10.1176/ajp.132.12.1237. View

13.

Brandon S, McClelland H, Protheroe C . A study of facial dyskinesia in a mental hospital population. Br J Psychiatry. 1971; 118(543):171-84. DOI: 10.1192/bjp.118.543.171. View

14.

SIEDE H, MULLER H . Choreiform movements as side effects of phenothiazine medication in geriatric patients. J Am Geriatr Soc. 1967; 15(6):517-22. DOI: 10.1111/j.1532-5415.1967.tb01191.x. View

15.

CRANE G . Dyskinesia and neuroleptics. Arch Gen Psychiatry. 1968; 19(6):700-3. DOI: 10.1001/archpsyc.1968.01740120060009. View

16.

Marsden C . Blepharospasm-oromandibular dystonia syndrome (Brueghel's syndrome). A variant of adult-onset torsion dystonia?. J Neurol Neurosurg Psychiatry. 1976; 39(12):1204-9. PMC: 492566. DOI: 10.1136/jnnp.39.12.1204. View

17.

ALTROCCHI P . Spontaneous oral-facial dyskinesia. Arch Neurol. 1972; 26(6):506-12. DOI: 10.1001/archneur.1972.00490120046004. View

18.

DEGKWITZ R, Binsack K, Herkert H, Luxenburger O, Wenzel W . [On the problem of persistent extrapyramidal hyperkinesia following prolonged use of neuroleptics]. Nervenarzt. 1967; 38(4):170-4. View

19.

Demars J . Neuromuscular effects of long-term phenothiazine medication, electroconvulsive therapy and leucotomy. J Nerv Ment Dis. 1966; 143(1):73-9. DOI: 10.1097/00005053-196607000-00008. View

20.

Greenblatt D, Dominick J, Stotsky B, DIMASCIO A . Phenothiazine-induced dyskinesia in nursing-home patients. J Am Geriatr Soc. 1968; 16(1):27-34. DOI: 10.1111/j.1532-5415.1968.tb03966.x. View